[PHARMA] YoY Annualized Quarter Result on 31-Mar-2010 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
26-May-2010
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2010
Quarter
31-Mar-2010 [#1]
Profit Trend
QoQ- -38.15%
YoY- -35.91%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
Revenue 2,001,356 1,786,980 1,541,312 1,270,240 1,254,864 1,238,600 1,024,940 11.78%
PBT 147,696 171,820 87,168 49,724 80,736 109,496 40,920 23.82%
Tax -47,084 -55,576 -24,772 -12,488 -21,964 -33,568 -14,948 21.05%
NP 100,612 116,244 62,396 37,236 58,772 75,928 25,972 25.29%
-
NP to SH 99,084 114,740 61,936 37,228 58,088 74,180 24,276 26.38%
-
Tax Rate 31.88% 32.35% 28.42% 25.11% 27.20% 30.66% 36.53% -
Total Cost 1,900,744 1,670,736 1,478,916 1,233,004 1,196,092 1,162,672 998,968 11.30%
-
Net Worth 484,829 474,161 437,661 439,675 402,378 367,905 321,111 7.10%
Dividend
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
Div 35,303 35,297 - - - - - -
Div Payout % 35.63% 30.76% - - - - - -
Equity
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
Net Worth 484,829 474,161 437,661 439,675 402,378 367,905 321,111 7.10%
NOSH 117,676 117,657 107,007 106,977 107,015 106,949 107,037 1.59%
Ratio Analysis
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
NP Margin 5.03% 6.51% 4.05% 2.93% 4.68% 6.13% 2.53% -
ROE 20.44% 24.20% 14.15% 8.47% 14.44% 20.16% 7.56% -
Per Share
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
RPS 1,700.72 1,518.79 1,440.38 1,187.40 1,172.60 1,158.12 957.56 10.03%
EPS 84.20 97.52 57.88 34.80 54.28 69.36 22.68 24.41%
DPS 30.00 30.00 0.00 0.00 0.00 0.00 0.00 -
NAPS 4.12 4.03 4.09 4.11 3.76 3.44 3.00 5.42%
Adjusted Per Share Value based on latest NOSH - 106,977
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
RPS 138.86 123.99 106.94 88.13 87.07 85.94 71.11 11.78%
EPS 6.87 7.96 4.30 2.58 4.03 5.15 1.68 26.42%
DPS 2.45 2.45 0.00 0.00 0.00 0.00 0.00 -
NAPS 0.3364 0.329 0.3037 0.3051 0.2792 0.2553 0.2228 7.10%
Price Multiplier on Financial Quarter End Date
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
Date 29/03/13 30/03/12 31/03/11 31/03/10 31/03/09 31/03/08 30/03/07 -
Price 8.26 5.90 5.73 4.27 3.45 2.95 3.55 -
P/RPS 0.49 0.39 0.40 0.36 0.29 0.25 0.37 4.78%
P/EPS 9.81 6.05 9.90 12.27 6.36 4.25 15.65 -7.48%
EY 10.19 16.53 10.10 8.15 15.73 23.51 6.39 8.08%
DY 3.63 5.08 0.00 0.00 0.00 0.00 0.00 -
P/NAPS 2.00 1.46 1.40 1.04 0.92 0.86 1.18 9.18%
Price Multiplier on Announcement Date
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
Date 15/05/13 03/05/12 13/05/11 26/05/10 08/05/09 28/05/08 25/05/07 -
Price 9.26 5.90 5.05 4.71 3.82 3.45 3.45 -
P/RPS 0.54 0.39 0.35 0.40 0.33 0.30 0.36 6.98%
P/EPS 11.00 6.05 8.72 13.53 7.04 4.97 15.21 -5.25%
EY 9.09 16.53 11.46 7.39 14.21 20.10 6.57 5.55%
DY 3.24 5.08 0.00 0.00 0.00 0.00 0.00 -
P/NAPS 2.25 1.46 1.23 1.15 1.02 1.00 1.15 11.82%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment